Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

37.80p
   
  • Change Today:
    -0.25p
  • 52 Week High: 118.00
  • 52 Week Low: 37.50
  • Currency: UK Pounds
  • Shares Issued: 70.63m
  • Volume: 108,340
  • Market Cap: £26.70m
  • RiskGrade: 453
  • Beta: 0.00

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -190.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.4 n/a
Pr/Book 0.6  
Latest F'cast
Revenue 84.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

NCYT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 277.20 165.17 194.00p 4.4 n/a n/a n/a 0.0%
31-Dec-21 92.60 (5.66) (9.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 21.04 (20.05) (31.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 10.62 (24.46) (34.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 19.63 (39.43) (55.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Company Announcements

Liquidity Agreement Monthly Update and TVR 02-May-2025 12:30 RNS
Full Year 2024 Results 30-Apr-2025 07:00 RNS
Notice of Results 22-Apr-2025 07:00 RNS

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

NCYT Market Data

Currency UK Pounds
Share Price 37.80p
Change Today -0.25p
% Change -0.66 %
52 Week High 118.00
52 Week Low 37.50
Volume 108,340
Shares Issued 70.63m
Market Cap £26.70m
Beta 0.00
RiskGrade 453

NCYT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.86% above the market average64.86% above the market average64.86% above the market average64.86% above the market average64.86% above the market average
76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average
Price Trend
64.34% below the market average64.34% below the market average64.34% below the market average64.34% below the market average64.34% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average
Income Not Available
Growth
6.96% above the market average6.96% above the market average6.96% above the market average6.96% above the market average6.96% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

NCYT Dividends

No dividends found

Trades for 02-May-2025

Time Volume / Share Price
16:35 10,805 @ 37.80p
16:35 2,253 @ 37.80p
16:35 4,082 @ 37.80p
16:35 2,241 @ 37.80p
16:35 2,188 @ 37.80p

NCYT Key Personnel

CFO Steve Gibson

Top of Page